ONE-WAYOngoing theme · still written in the latest filings
Out-licensing of TMS-007 and Late-Stage Phase II Clinical Trial
A project under which late Phase II clinical development is being advanced in the CORXEL-led ORION trial following out-licensing to Biogen, with continued subject enrollment, including in Japan, and ancillary cooperation by the Company.
Companies1How many companies write about this.
Threads1One company can carry more than one thread here.
PeriodFY2023-Q3 →Still being written about.
Directionhelps1 helps · 0 hurts · 0 flat